Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-10-26

Clinical Trial Update: Progesterone for First Trimester Vaginal Bleeding [NA]

View source ↗

Summary

Clinical trial NCT01501890 evaluating progesterone for first-trimester vaginal bleeding has been withdrawn. Sponsor: Soroka University Medical Center; condition…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PROGESTERONE (Progesterone)

Snippet

Sponsor: Soroka University Medical Center | Conditions: Threatened Abortion, Pre-Eclampsia | NA | Status: WITHDRAWN